申请人:Aldeyra Therapeutics, Inc.
公开号:US20160168098A1
公开(公告)日:2016-06-16
Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed